Oricell Therapeutics

Health Care, Pharmaceutical, Product Research
Founded in 1/1/15
Shanghai, Shanghai, China
For Profit

About Oricell Therapeutics

OriCell Therapeutics develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives to become the world-leading developer of novel drugs for tumor immunotherapy.

Company Metrics

  • Employees: 101-250
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 165492876 USD
  • Last Funding: 120000000 USD (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

Oricell Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Health Care, Pharmaceutical, Product Research

Headquarters: Shanghai, Shanghai, China